Choose the bounded laboratory action

This case requires an urgent concern level, not a final leukemia classification. The preferred action is to describe the blast-like cells and Auer rods, protect suitable material for ancillary studies, and activate the locally approved urgent communication route. Calling the case APL or AML from morphology alone exceeds the evidence.

A laboratory director, in consultation with clinicians served, defines which results are critical and who must receive notification. CAP requires immediate notification when designated critical values are exceeded and retention of notification records; the exact trigger, timeframe, escalation ladder, read-back practice, component release, hold, and manual-differential rules are local policy. Follow the approved route even when the total leukocyte count is low, normal, or high.

The answer must include the studies needed before classification: flow cytometry for abnormal population and lineage assessment, conventional cytogenetics and karyotype, FISH, and molecular testing for complementary genetic information. A rapid PML::RARA assay is particularly relevant to the morphology concern in this case. Escalate the observed urgent pattern and preserve the path to confirmation, rather than trying to settle the diagnosis at the bench.